3 October 2016 - Deborah Wilkes
Read all about Bayer's adjusted model for its global Consumer Health business in this NEWS EXTRA publication from OTCToolbox.
Two years after acquiring Merck & Co's Consumer Care operations for US$14.2 billion, Bayer has adjusted the model for its Consumer Health business.
The "more sophisticated" approach was recently set out by Werner Baumann, Bayer's chief executive officer, and Erica Mann, head of Bayer Consumer Health.
Download the publication today to find out about Bayer Consumer Health's plans for:
- "Refocusing" investments towards mature markets
- Continuing "prudent" investments in emerging markets
- Accelerating "consumer-centric innovation"
- Addressing weaknesses in the former Merck & Co brands
- Driving growth in key markets
- Leveraging scale to grow more profitably
The 20-page News Extra is available to purchase and download immediately from the OTCToolbox website. You can make sure your team is well informed through a Multiple User Licence or a Global Licence.
This essential reading is available free to people with an Annual Subscription to the OTCToolbox website (click here to find out more).
RAPID INSIGHTS MADE EASY
AVAILABLE TO DOWNLOAD IMMEDIATELY AS A PDF
See Payment Options box at the top of this page
For alternative payment options and delivery methods, or other questions, please send an email to firstname.lastname@example.org.